Sarepta Therapeutics, Inc.

Stocks

SRPT

US8036071004

Real-time Estimate Cboe BZX Other stock markets 12:45:12 22/07/2026 am IST			5-day change	1st Jan Change
16.12 ^USD	-4.25%		-10.23%	-25.08%

30/06	Sarepta Therapeutics Announces FDA Acceptance Of Supplemental New Drug Applications For Amondys 45 And Vyondys 53 For Duchenne Muscular Dystrophy	CI
30/06	Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications	MT

Transcript : Sarepta Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10

Published on 06/08/2026 at 09:50 pm IST - Modified on 06/09/2026 at 12:05 am IST

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Salveen Richter (Analysts)

Great. Good morning, everyone. It's my pleasure to introduce the Sarepta team. With us, we have Doug Ingram, CEO; Ian Estepan, President and COO; Ryan Wong,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Sarepta Therapeutics, Inc.

30/06	Sarepta Therapeutics Announces FDA Acceptance Of Supplemental New Drug Applications For Amondys 45 And Vyondys 53 For Duchenne Muscular Dystrophy	CI
30/06	Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications	MT
30/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell Midcap Growth Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Value Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Growth Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Growth Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Dynamic Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Dynamic Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell Midcap Value Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell Midcap Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Value Benchmark	CI
18/06	Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says	MT
08/06	Sarepta Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:40 AM